What is Radix Biosolutions?
Radix Biosolutions specializes in the development of custom microsphere-based assay products. Catering to clients in research, drug discovery, and agriculture, the company focuses on creating assays specifically for the Luminex xMAP Platform. Leveraging over 14 years of combined experience in xMAP assay development and 5 years of industry research, Radix Biosolutions is positioned to deliver high-quality, tailored assay solutions efficiently and economically.
How much funding has Radix Biosolutions raised?
Radix Biosolutions has raised a total of $139K across 1 funding round:
Debt
$139K
Debt (2021): $139K with participation from PPP
What's next for Radix Biosolutions?
The substantial backing received by Radix Biosolutions in this late-stage funding round is expected to accelerate its growth and market penetration. This strategic investment will likely fuel further innovation in assay development, enhance production capabilities, and expand its reach within the research, pharmaceutical, and agricultural sectors. The company's focus on custom solutions for the Luminex xMAP Platform positions it for continued success in a specialized market.
See full Radix Biosolutions company page